ProShare Advisors’s Stoke Therapeutics STOK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $119K | Buy |
10,444
+280
| +3% | +$3.18K | ﹤0.01% | 1847 |
|
|
2025
Q1 | $67.6K | Sell |
10,164
-2,462
| -19% | -$16.4K | ﹤0.01% | 1912 |
|
|
2024
Q4 | $139K | Buy |
+12,626
| New | +$139K | ﹤0.01% | 1993 |
|
|
2022
Q1 | – | Sell |
-9,346
| Closed | -$224K | – | 2296 |
|
|
2021
Q4 | $224K | Sell |
9,346
-948
| -9% | -$22.7K | ﹤0.01% | 1960 |
|
|
2021
Q3 | $262K | Sell |
10,294
-1,255
| -11% | -$31.9K | ﹤0.01% | 1642 |
|
|
2021
Q2 | $389K | Buy |
11,549
+2,910
| +34% | +$98K | ﹤0.01% | 1713 |
|
|
2021
Q1 | $336K | Buy |
8,639
+300
| +4% | +$11.7K | ﹤0.01% | 1729 |
|
|
2020
Q4 | $516K | Buy |
8,339
+1,482
| +22% | +$91.7K | ﹤0.01% | 1257 |
|
|
2020
Q3 | $230K | Buy |
+6,857
| New | +$230K | ﹤0.01% | 1339 |
|
|
2020
Q1 | – | Sell |
-8,317
| Closed | -$236K | – | 1538 |
|
|
2019
Q4 | $236K | Buy |
+8,317
| New | +$236K | ﹤0.01% | 1486 |
|